LRRC40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.916500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.521900E-02
Normal-vs-Stage2
1.021620E-01
Normal-vs-Stage3
8.596900E-03
Normal-vs-Stage4
4.074000E-01
Stage1-vs-Stage2
5.936200E-01
Stage1-vs-Stage3
3.388200E-01
Stage1-vs-Stage4
2.856200E-01
Stage2-vs-Stage3
1.411230E-01
Stage2-vs-Stage4
3.856000E-01
Stage3-vs-Stage4
7.940100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.608400E-02
Normal-vs-AfricanAmerican
2.906200E-01
Normal-vs-Asian
2.372400E-02
Caucasian-vs-AfricanAmerican
5.612600E-01
Caucasian-vs-Asian
2.108000E-01
AfricanAmerican-vs-Asian
2.156400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.984500E-02
Normal-vs-Female
1.902030E-01
Male-vs-Female
4.064100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.635800E-02
Normal-vs-Age(41-60Yrs)
2.126400E-01
Normal-vs-Age(61-80Yrs)
6.839900E-02
Normal-vs-Age(81-100Yrs)
2.332300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.964400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.742400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.942600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.026100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.786400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.905200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.276250E-02
Normal-vs-Daily Drinker
9.399600E-03
Normal-vs-Weekly Drinker
3.607800E-02
Normal-vs-Occasional Drinker
2.526600E-01
Normal-vs-Social Drinker
3.292800E-01
Non Drinker-vs-Daily Drinker
5.400200E-01
Non Drinker-vs-Weekly Drinker
7.983600E-01
Non Drinker-vs-Occasional Drinker
9.526400E-02
Non Drinker-vs-Social Drinker
1.808840E-01
Daily Drinker-vs-Weekly Drinker
4.688400E-01
Daily Drinker-vs-Occasional Drinker
5.118400E-02
Daily Drinker-vs-Social Drinker
7.116500E-02
Weekly Drinker-vs-Occasional Drinker
2.664400E-01
Weekly Drinker-vs-Social Drinker
2.985800E-01
Occasional Drinker-vs-Social Drinker
9.596000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.355800E-01
Normal-vs-Grade 2
7.902400E-01
Normal-vs-Grade 3
4.227400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.064400E-01
Grade 1-vs-Grade 3
1.882030E-01
Grade 1-vs-Grade 4
7.355800E-01
Grade 2-vs-Grade 3
5.309600E-01
Grade 2-vs-Grade 4
7.902400E-01
Grade 3-vs-Grade 4
4.227400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.548400E-02
Normal-vs-NonDiabetic
5.664200E-02
Diabetic-vs-NonDiabetic
3.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.259760E-03
Normal-vs-NoPancreatitis
6.298100E-02
Pancreatitis-vs-NoPancreatitis
7.320100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.347630E-01
Normal-vs-N1
8.397500E-02
N0-vs-N1
5.944600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.176000E-01
Normal-vs-TP53-NonMutant
1.119200E-01
TP53-Mutant-vs-TP53-NonMutant
3.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
